Tuesday 13 October 2026
Export CLX’s income statement to Excel — free account
The Clorox Company
CLX Consumer Defensive Household & Personal Products
The Clorox Company’s revenue for fiscal 2026 (year ended June 2026) was $6.7 billion, down 5.41% from fiscal 2025. In the quarter to June 2026, revenue fell 2.01%, EPS fell 50.4%, free cash flow grew 11.4% and total debt rose 60.3%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for twenty-five consecutive years; insiders bought in the last twelve months.
84.35
0.55
+0.66%
Follow CLX
Target Price Range
Analyst price targets
Free accountTen years at a glance Fiscal years to June
| Group | Line | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | Trend | 2027e | 2028e | 2029e |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Price, $ | |||||||||||||||
| Price, $ | Low | 118.41 | 113.57 | 143.58 | 150.95 | 156.23 | 120.50 | 114.69 | 127.60 | 96.66 | 79.12 |
Analyst estimates 2027–2029 Powerpack |
|||
| High | 150.40 | 167.70 | 166.90 | 239.87 | 231.11 | 186.86 | 178.21 | 171.37 | 164.22 | 128.90 | |||||
| People | |||||||||||||||
| People | Employees | 8,100 | 8,700 | 8,800 | 8,800 | 9,000 | 9,000 | 8,700 | 8,000 | 7,600 | 9,200 | ||||
| Revenue/emp, $m | 0.74 | 0.70 | 0.71 | 0.76 | 0.82 | 0.79 | 0.85 | 0.89 | 0.93 | 0.73 | |||||
| Income, $m | |||||||||||||||
| Income, $m | Revenue | 5,973 | 6,124 | 6,214 | 6,721 | 7,341 | 7,107 | 7,389 | 7,093 | 7,104 | 6,720 | ||||
| Gross margin, % | 44.72 | 43.68 | 43.90 | 45.57 | 43.58 | 35.81 | 39.36 | 42.97 | 45.23 | 42.32 | |||||
| EBT | 1,033 | 1,054 | 1,024 | 1,185 | 900 | 607 | 238 | 398 | 1,078 | 791 | |||||
| EBT margin, % | 17.29 | 17.21 | 16.48 | 17.63 | 12.26 | 8.54 | 3.22 | 5.61 | 15.17 | 11.77 | |||||
| Net income | 701 | 823 | 820 | 939 | 719 | 471 | 161 | 292 | 824 | 601 | |||||
| Depreciation | 163 | 166 | 180 | 180 | 540 | 224 | 681 | 235 | 219 | 247 | |||||
| Per share, $ | |||||||||||||||
| Per share, $ | Revenue | 46.32 | 47.37 | 48.65 | 53.41 | 58.46 | 57.73 | 59.79 | 57.12 | 57.51 | 55.18 | ||||
| Earnings | 5.43 | 6.37 | 6.42 | 7.46 | 5.66 | 3.75 | 1.21 | 2.26 | 6.56 | 4.82 | |||||
| Cash flow | 6.71 | 7.55 | 7.77 | 12.29 | 10.16 | 6.38 | 9.37 | 5.60 | 7.94 | 5.03 | |||||
| Capex | (1.79) | (1.50) | (1.61) | (2.02) | (2.64) | (2.04) | (1.84) | (1.71) | (1.78) | (1.70) | |||||
| Free cash flow | 4.92 | 6.05 | 6.15 | 10.27 | 7.53 | 4.35 | 7.52 | 3.89 | 6.16 | 3.33 | |||||
| Book value | 4.20 | 5.62 | 4.38 | 7.22 | 4.71 | 5.92 | 3.14 | 3.96 | 3.90 | 2.07 | |||||
| Shares, m | 129 | 129 | 128 | 126 | 126 | 123 | 124 | 124 | 124 | 122 | |||||
| Valuation, × | |||||||||||||||
| Valuation, × | P/E | 24.49 | 20.93 | 23.73 | 29.41 | 31.90 | 37.70 | 130.36 | 59.66 | 18.30 | 19.80 | ||||
| P/S | 2.88 | 2.82 | 3.14 | 4.11 | 3.08 | 2.44 | 2.66 | 2.35 | 2.09 | 1.73 | |||||
| P/B | 31.70 | 23.78 | 34.92 | 30.40 | 38.16 | 23.81 | 50.66 | 33.88 | 30.77 | 46.12 | |||||
| EV/Sales | 3.11 | 3.24 | 3.56 | 4.40 | 3.41 | 2.81 | 2.97 | 2.73 | 2.48 | 2.30 | |||||
| EV/FCF | 29.27 | 25.34 | 28.11 | 22.89 | 26.51 | 37.32 | 23.56 | 40.13 | 23.11 | 38.18 | |||||
| Cash, $m | |||||||||||||||
| Cash, $m | Operating cash flow | 865 | 976 | 992 | 1,546 | 1,276 | 786 | 1,158 | 695 | 981 | 612 | ||||
| Capex | (231) | (194) | (206) | (254) | (331) | (251) | (228) | (212) | (220) | (207) | |||||
| Free cash flow | 634 | 782 | 786 | 1,292 | 945 | 535 | 930 | 483 | 761 | 405 | |||||
| Balance, $m | |||||||||||||||
| Balance, $m | Working capital | (295) | 111 | (135) | 602 | (227) | (59) | (89) | 48 | (311) | (949) | ||||
| Total debt | 1,791 | 2,483 | 2,683 | 2,846 | 2,784 | 2,795 | 2,623 | 2,481 | 2,484 | 3,982 | |||||
| Net debt | 1,373 | 2,352 | 2,572 | 1,975 | 2,465 | 2,612 | 2,256 | 2,279 | 2,317 | 3,839 | |||||
| Shareholders’ equity | 542 | 726 | 559 | 908 | 592 | 729 | 388 | 492 | 482 | 252 | |||||
| Returns, % | |||||||||||||||
| Returns, % | ROA | 15.44 | 17.09 | 16.12 | 16.58 | 11.32 | 7.40 | 2.46 | 4.79 | 14.32 | 8.79 | ||||
| ROIC | 36.78 | 23.07 | 22.44 | 27.62 | 18.95 | 14.03 | 9.64 | 11.55 | 24.12 | 13.95 | |||||
| ROE | 167.10 | 129.81 | 127.63 | 128.02 | 94.67 | 69.95 | 26.68 | 63.64 | 166.32 | 159.95 | |||||
Negative figures in brackets.
Fiscal years to Jun 2026 · latest quarter Jun 2026
Charts ten years each
The Clorox Company vs peers in Household & Personal Products (Q) = latest quarter vs a year earlier
| Company | Market cap | P/E | Fwd P/E | Revenue growth (Q) | EPS growth (Q) | FCF growth (Q) | Gross margin (Q) | EBIT margin (Q) | Compare |
|---|---|---|---|---|---|---|---|---|---|
| EL The Estee Lauder Companies Inc. | $35.5B | 196× | 28.0× | +6.33% (above 0%: growing) | n/m | +7.87% (above 0%: growing) | 75.46% | (1.08%) | Compare |
| KVUE Kenvue Inc. | $34.0B | 20.5× | 18.6× | +3.02% (above 0%: growing) | +9.09% (above 0%: growing) | +17.07% (above 0%: growing) | 58.18% | 17.67% | Compare |
| KMB Kimberly-Clark Corporation | $32.5B | 16.8× | 14.4× | +0.62% (above 0%: growing) | −32.03% (below 0%: shrinking) | −4.79% (below 0%: shrinking) | 38.27% | 15.11% | Compare |
| CHD Church & Dwight Co., Inc. | $23.3B | 32.0× | 26.3× | +1.57% (above 0%: growing) | +10.26% (above 0%: growing) | +23.33% (above 0%: growing) | 45.35% | 18.07% | Compare |
| CLX The Clorox Company | $10.1B | 17.5× | 14.8× | −2.01% (below 0%: shrinking) | −50.37% (below 0%: shrinking) | +11.42% (above 0%: growing) | 41.27% | 13.24% | |
| ELF e.l.f. Beauty | $6.5B | 110× | 21.2× | +35.52% (above 0%: growing) | +91.53% (above 0%: growing) | +447.39% (above 0%: growing) | 83.20% | 21.37% | Compare |
| IPAR Interparfums, Inc. | $3.6B | 21.5× | 18.8× | +2.13% (above 0%: growing) | −5.00% (below 0%: shrinking) | +1,031.52% (above 0%: growing) | 65.54% | 14.35% | Compare |
| COTY Coty | $2.5B | — (loss-making) | 11.8× | +1.34% (above 0%: growing) | n/m | +20.86% (above 0%: growing) | 60.88% | (3.36%) | Compare |
| NWL Newell Brands Inc. | $2.4B | — (loss-making) | 7.4× | +3.05% (above 0%: growing) | +127.27% (above 0%: growing) | +84.62% (above 0%: growing) | 40.72% | 14.19% | Compare |
| Median of peers | $14.9B | 26.7× | 18.7× | +2.58% | +9.68% | +22.10% | 59.53% | 14.73% |
CLX metrics, ten years each
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
The Clorox Company (CLX) key facts
- Concern: The Clorox Company’s revenue for fiscal 2026 (year ended June 2026) was $6.7 billion, down 5.41% from fiscal 2025.
- Concern: Net income was $601.0 million, or $4.82 per share (basic), a net margin of 8.74%.
- The Clorox Company (CLX) is a Household & Personal Products company in the Consumer Defensive sector, listed on the New York Stock Exchange.
- As of October 12, 2026, CLX traded at $84.35, a market capitalization of $10.2 billion.
- At that price the stock trades at 17.5× trailing-twelve-month earnings and 1.5× sales; its P/E is higher than 5% of its own readings over the past ten years.
- The Clorox Company pays an annual dividend of $6.22 per share, a yield of 7.37%, with a payout ratio of 129.1%.
- Return on equity was 160.0% and debt-to-equity 15.80.
- Its Piotroski F-score is 4 out of 9 and its Altman Z-score is 2.10 (grey zone) for fiscal 2026.
The Clorox Company (CLX) Latest News
No news at this impact. Lower the threshold for more.